BMJ  2004;328:118-119 (17 January), doi:10.1136/bmj.328.7432.118

Editorial

Recipients of blood or blood products "at vCJD risk"

We need to define their rights and responsibilities and those of others

The first 150 words of the full text of this article appear below.

In December 2003 the health secretary, John Reid, told parliament of the death of the first probable victim of variant Creutzfeldt-Jakob disease (vCJD) after being transfused blood in 1996 from a donor who had been incubating vCJD.1 The disease manifested in the donor in 1999, who died from it. This is the first probable case of transmission of vCJD following blood transfusion. The incubation period of under seven years in the recipient was notably short—consistent with human to human transmission.2 We now need to take steps to define the rights and responsibilities of recipients of "at vCJD risk" blood and blood products and also those of the rest of the population. These steps promise to be expensive and intrusive and have enormous implications for those at risk.3

The issues faced are more parlous than for HIV, against which the blood supply is protected by HIV testing and surgical instruments by . . . [Full text of this article]

Sheila M Bird, senior statistician

MRC Biostatistics Unit, Cambridge CB2 2SR


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

In brief
BMJ 2006 332: 380. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • BUTLER, R. (2006). Prion diseases in humans: an update. Br. J. Psychiatry 189: 295-296 [Abstract] [Full text]  
  • (2006). In brief. BMJ 332: 380-380 [Full text]  
  • Duncan, R E, Delatycki, M B, Collins, S J, Boyd, A, Masters, C L, Savulescu, J (2005). Ethical considerations in presymptomatic testing for variant CJD. J. Med. Ethics 31: 625-630 [Abstract] [Full text]  
  • Bosse, D., Praus, M., Kiessling, P., Nyman, L., Andresen, C., Waters, J., Schindel, F. (2005). Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin. J Clin Pharmacol 45: 57-67 [Abstract] [Full text]  
  • Norfolk, D R, Glaser, A, Kinsey, S (2005). American fresh frozen plasma for neonates and children. Arch. Dis. Child. 90: 89-91 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Protecting a future nation.
Stephen J Katona
bmj.com, 30 Jan 2004 [Full text]
A Plea for Sanity in Assessment of Risk
George A Venters
bmj.com, 2 Feb 2004 [Full text]
Fully informed
Stephen J Katona
bmj.com, 2 Feb 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ